spacer
home > epc > spring 2018 > data diligence
PUBLICATIONS
European Pharmaceutical Contractor

Data Diligence

Following headlines covering the Facebook and Cambridge Analytica saga, awareness of not only privacy issues, but also the underlying value of data held by corporations and how they are processed has heightened. One area highlighted in this article is how data collected by pharmaceutical companies is underutilised to inform data-driven decisionmaking across the board.

Unlocking Marketing Data

Traditionally, supply chain design and management has focused solely on sourcing products as well as distribution. However, many pharma companiesí supply chains are based on outdated legacy models where high demand and margins were once the norm. With the emergence of generic products, expiring patents, over-the-counter products, and an increased focus on emerging markets to deliver competitiveness, pharma companies need to design and introduce new supply chain models that require new systems, processes, and metrics to be implemented. The definition of supply chain management has broadened over the years, and, in the data-centric world people live in today, supply chain decision makers have begun realising the importance of regulatory, market, and healthcare professional client data, in designing more competitive supply chain models.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kieran Bourke at MAXX Design is focused on the development of marketing solutions for pharma companies and has previously worked closely with GSK across its consumer marketing portfolio, helping them to innovate around the rapid rise of mobile marketing. He was previously a spokesperson for the Institute of Practitioners in Advertising.
spacer
Kieran Bourke
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for twelve countries in Asia Pacific

Novo Nordisk Pharmatech A/S and DKSH, have partnered to provide high-quality cGMP quaternary ammonium compounds in twelve countries across Asia Pacific
More info >>

White Papers

7 Common Myths about QP Training Debunked: A Guide for Senior Managers

RSSL

The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >>

 
Industry Events

10th Annual Summit for Clinical Ops Executives

18-21 February 2019, Hyatt Regency Orlando, Florida

Celebrating its 10th successful year, SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 19 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including...
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement